Charles River Navigator Services provides scientific and regulatory advice to clients to ensure that their preclinical development programs meet with regulatory agencies’ expectations. Navigators accomplish this goal by sharing their own wealth of expertise and by leveraging the scientific and regulatory expertise found across the Charles River global network for the benefit of their clients.
Navigators employ former senior FDA pharmacology/toxicology reviewers and senior scientists from the pharmaceutical industry with established expertise in drug development. Their expertise spans all therapeutic areas and product types, including small molecules, biotechnology-derived proteins, synthetic peptides, vaccines and cell/gene therapy.